[S-28] Symposium 28 Novel therapeutic strategies against ischemic stroke from the perspective of neuro-glial-vascular unit

[S-28-1] Endothelial progenitor cells secretome in neuro-oligo-vascular remodeling after ischemic stroke

^○Anna Rosell (Neurovascular Research Laboratory, Institut de Recerca, Hospital Vall d'Hebron, Barcelona, Spain)

My scientific education and expertise has been focused in the translational study of stroke. As a PhD student at Vall d’Hebron Research Institute (VHIR, Barcelona), I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. At the Massachusetts General Hospital in a world-leading laboratory of experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH) I did a postdoctoral training extending my experience at a more basic and experimental level. A step forward in my career was the establishment of a new neurorepair research group as principal investigator at the Neurovascular Research Laboratory at VHIR with a tenure-track appointment, and since 2016 I hold a tenured position and I am the head of the Laboratory. The focus of my research is the search of new therapies for stroke based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches. This has allowed me to obtain funding as PI from national and international agencies and private foundations, to supervise and guide PhD Students and postdoctoral researchers. I have established collaborations within the neuroscience, regenerative medicine and nanotechnology fields with over 100 publications.